SAGE THERAPEUTICS INC (SAGE) Stock Income Statement
NASDAQ:SAGE - Nasdaq - US78667J1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.40M | 41.24M | 86.45M | 7.70M | 6.30M | |||
| Cost Of Goods | 8.83M | 9.44M | 2.16M | 800.00K | 600.00K | |||
| Gross Profit | 38.58M | 31.80M | 84.30M | 6.90M | 5.80M | |||
| Operating Expenses | 398.36M | 442.31M | 630.76M | 553.90M | 466.60M | |||
| Research and Development | 176.92M | 225.90M | 356.24M | 326.20M | 283.20M | |||
| Selling, General, and Administrative Expenses | 221.44M | 216.42M | 274.52M | 227.70M | 183.50M | |||
| Operating Income | -359.78M | -410.52M | -546.46M | -547.00M | -460.90M | |||
| Interest Income/Expense | 27.69M | 31.68M | 38.74M | 14.20M | 2.90M | |||
| Other Income/Expense | 60.00K | 29.00K | -383.00K | 0.00 | 100.00K | |||
| Non Recurring Items | N/A | -21.85M | -33.39M | 0.00 | 0.00 | |||
| Income Before Taxes | -354.40M | -400.67M | -541.49M | -532.80M | -457.90M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -354.40M | -400.67M | -541.49M | -532.80M | -457.90M | |||
| EBITDA | -358.98M | -409.49M | -545.07M | -545.90M | -456.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.80 | -6.59 | -9.05 | -8.98 | -7.80 | |||
| Non GAAP EPS | -5.80 | -6.59 | -10.31 | -8.98 | -7.80 | |||
| Statistics | ||||||||
| Gross Profit Margin | 81.37% | 77.10% | 97.50% | 89.61% | 92.06% | |||
| Profit Margin | -747.61% | -971.48% | -626.32% | -6919.48% | -7268.25% | |||
| Operating Profit Margin | -758.97% | -995.36% | -632.08% | -7103.90% | -7315.87% | |||
All data in USD